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Abstract
Background: Schistosoma haematobium, the helminth causing urogenital schistosomiasis, is a known bladder
carcinogen. Despite the causal link between S. haematobium and bladder cancer, the underlying mechanisms are
poorly understood. S. haematobium oviposition in the bladder is associated with angiogenesis and urothelial
hyperplasia. These changes may be pre-carcinogenic events in the bladder. We hypothesized that the Interleukin-4-
inducing principle of Schistosoma mansoni eggs (IPSE), an S. haematobium egg-secreted “infiltrin” protein that
enters host cell nuclei to alter cellular activity, is sufficient to induce angiogenesis and urothelial hyperplasia.
Methods: Mouse bladders injected with S. haematobium eggs were analyzed via microscopy for angiogenesis and
urothelial hyperplasia. Endothelial and urothelial cell lines were incubated with recombinant IPSE protein or an IPSE
mutant protein that lacks the native nuclear localization sequence (NLS-) and proliferation measured using CFSE
staining and real-time monitoring of cell growth. IPSE’s effects on urothelial cell cycle status was assayed through
propidium iodide staining. Endothelial and urothelial cell uptake of fluorophore-labeled IPSE was measured.
Findings: Injection of S. haematobium eggs into the bladder triggers angiogenesis, enhances leakiness of bladder
blood vessels, and drives urothelial hyperplasia. Wild type IPSE, but not NLS-, increases proliferation of endothelial
and urothelial cells and skews urothelial cells towards S phase. Finally, IPSE is internalized by both endothelial and
urothelial cells. Interpretation: IPSE drives endothelial and urothelial proliferation, which may depend on
internalization of the molecule. The urothelial effects of IPSE depend upon its NLS. Thus, IPSE is a candidate pro-
carcinogenic molecule of S. haematobium.
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Summary: Schistosoma haematobium acts as a bladder carcinogen through unclear mechanisms. The S.
haematobium homolog of IPSE, a secreted schistosome egg immunomodulatory molecule, enhances angiogenesis
and urothelial proliferation, hallmarks of pre-carcinogenesis, suggesting IPSE is a key pro-oncogenic molecule of S.
haematobium.
Introduction
Urogenital schistosomiasis (UGS), primarily infection by
the blood fluke, Schistosoma haematobium, affects the
bladder and other pelvic organs. Egg deposition by the
adult stage of the parasite in the bladder during infection
is notable for its association with hematuria and bladder
angiogenesis [1]. This suggests that this parasitic worm
triggers aberrant host endothelial responses. S. haemato-
bium oviposition is also linked to urothelial alterations
such as hyperplasia [1–6]. It is unknown, however, if
other factors produced by the S. haematobium adult
worms, which live in the pelvic veins, also contribute to
the bladder endothelial and urothelial changes of UGS.
Both abnormal angiogenesis and epithelial hyperplasia
have been associated with pre-carcinogenic changes in
endodermal organs. Indeed, UGS is categorized as a
group 1 carcinogen, i.e., deemed to cause cancer in
humans, by the International Agency for Research on
Cancer [7]. It is, however, unclear which components of
S. haematobium eggs are pro-oncogenic.
One major protein secreted by the egg of S. haemato-
bium is the ortholog of interleukin-4-inducing principle
(IPSE) of the egg of the congener, Schistosoma mansoni,
in which it was first discovered [8]. S. mansoni IPSE
features numerous host modulatory properties. As indi-
cated by its name, IPSE leads to secretion of IL-4 from
basophils and mast cells by engaging IgE bound to the
high affinity IgE receptor on these two cell types. IPSE
also contains a nuclear localization sequence which
guides the protein into the nuclei of host cells and
presumably alters cellular activity [9, 10]. We have
demonstrated that H03-H-IPSE, one of the major S.
haematobium orthologs of IPSE [11], induces prolifera-
tion of mouse urothelial cells in vitro in a nuclear
localization sequence-dependent manner [12]. Further-
more, H06-H-IPSE, another major S. haematobium
ortholog of IPSE, is internalized by both urothelial and
neuronal cells [13], indicating that IPSE may be taken up
by and influence diverse cell types. This led us to
hypothesize that IPSE drives proliferation of human
urothelial cells, skews them towards S-phase of the cell
cycle, and also induces angiogenesis.
Here we demonstrate that S. haematobium eggs, in
the absence of S. haematobium adult stage worms, are
sufficient to initiate the bladder endothelial and urothe-
lial alterations of urogenital schistosomiasis. Further-
more, we show in vitro that H03-H-IPSE is taken up by
both endothelial and urothelial cells. H03-H-IPSE
triggers angiogenic behavior in endothelial cells in
culture and orchestrates urothelial proliferation and S-




Female 6- to 7-wk-old BALB/c mice (Charles River La-
boratories, Wilmington, MA, USA) were housed under
12 h light- dark cycles in temperature-controlled holding
rooms with unlimited access to dry mouse chow and
water. Newly received mice were acclimated to the ani-
mal facility for at least 1 week prior to experimental use.
IPSE protein production and labeling
Recombinant H03 H-IPSE, H06 H-IPSE, and an NLS
mutant of H03 H-IPSE (the wild type NLS sequence
SKRRRKY changed to SAAGAAY) were produced in
HEK293-6E cells, and then purified via immobilized-
metal affinity chromatography using an 8x His tag in the
construct as described [11]. H03 H-IPSE was conjugated
to Alexa Fluor 488 using a Alexa Fluor 488 antibody la-
beling kit (Thermofisher Scientific, Waltham, MA) ac-
cording to the manufacturer’s instructions; however, the
pH was kept at 7.4 throughout the reaction to enrich for
labeling of the terminal amine (pKa of 7.4). The effi-
ciency of conjugation was confirmed by Nanodrop. The
typical level of labeling was one mole of dye per mole of
IPSE, which suggested IPSE was only labeled on the ter-
minal amine. Avoiding labelling of lysine or arginine res-
idues in the protein backbone is critical, as each of the
positively charged amino acids in the NLS is essential
for nuclear translocation [9]. Low labeling efficiency thus
minimized the potential interference of the dye with
IPSE’s functional domains.
S. haematobium egg injection
Bladder wall injections were performed as described pre-
viously [14]. Female BALB/c mice were anesthetized
with isoflurane, a midline lower abdominal incision was
made, and the bladder was exteriorized. S. haematobium
eggs (3000 eggs in 50 μl) were injected into the wall of
the bladder. Abdominal incisions were subsequently
closed with 4–0 Vicryl sutures, and the surgical site was
treated once with topical antibiotic ointment.
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Histology
Bladder tissues were fixed in neutral buffered formalin,
dehydrated, and embedded in paraffin. Five-micrometer
sections were stained with hematoxylin and eosin. Hist-
ology was analyzed by a board-certified pathologist (JIO)
in a blinded fashion.
Ex vivo angiogenesis and microvascular leakage
microscopy
Microvascular leakage was assessed 3 weeks following S.
haematobium egg or vehicle injection using an estab-
lished protocol [15]. This protocol involves the use of
FITC-lectin to gauge vessels that are being perfused
while also providing anatomic detail. Briefly, following
FITC-lectin injection, 100 μL R50 Fluoro-Max red fluor-
escent microspheres, 0.048 μm in diameter (Thermo
Scientific), were injected through the inferior vena cava.
After 3–5 min in circulation, a sternotomy was
performed, and the aorta was cannulated via the left
ventricle with an 18-gauge angiocatheter and perfused
with 1% paraformaldehyde for 3–5 min using a mini
pump (Fisher Scientific). Grafts were harvested and
mounted as described above. Microvascular permeability
was assessed by using confocal microscopy to determine
the extent of microsphere extravasation.
Proliferation xCELLigence assay
Cells were seeded at 5000 cells per well in 200 μl of
complete media in E-plates (ACEA Biosciences, San
Diego, CA, USA) and grown overnight while monitored
with an xCELLigence DP system (ACEA Biosciences)
which monitors cellular events in real time by measuring
electrical impedance across interdigitated gold micro-
electrodes integrated on the bottom of tissue culture
plates [16, 17]. Cells were washed three times with PBS
and cultured with 180 μl EGM-2 basal media (no growth
factors or supplements) and incubated for a minimum of
6 h before further treatment. Treatments were prepared
at 10 × concentrations and added to each well in a total
volume of 20 μl. The xCELLigence DP recorded cell
index readings every 15 min for 3 days after treatment.
Cell index readings were normalized before treatment
and cell proliferation ratios were determined from four
biological replicates and represent the relative numbers
of cells compared to control cells. A two-way ANOVA
with Holm–Sidak’s multiple comparisons test was used
to compare IPSE treatment to medium-alone control,
with P ≤ 0.05 deemed significant.
Cell lines
3B-11 and EOMA cells were obtained from ATCC (Ma-
nassas, Virginia). ATCC uses morphology, karyotyping,
and PCR based approaches to confirm the identity of
human cell lines and to rule out both intra- and
interspecies contamination. These include an assay to
detect species specific variants of the cytochrome C oxi-
dase I gene (COI analysis) to rule out inter-species con-
tamination and short tandem repeat (STR) profiling to
distinguish between individual human cell lines and rule
out intra-species contamination. HCV-29 cells were ob-
tained from Dra. Monica Botelho. These cells have
undergone STR profiling using the following markers:
amelogenin, D8S1179, D18S51, D21S11, FGA, TH01,
and vWA. The 3B-11, EOMA, and HCV-29 cells were
Mycoplasma-free as established using the Lookout
Mycoplasma PCR detection kit (Sigma-Aldrich).
Tubule formation assay
Growth factor-reduced Matrigel (Corning, Corning, NY,
USA) was plated into a 96-well μ-angiogenesis plate (ibidi,
Planegg, Germany) at 10 μl/well, and incubated at 37 °C in
5% CO2 in air for 60min as described [18]. 3B-11 cells
were detached using Trypsin/EDTA and resuspended in
DMEM (Gibco), and seeded at 30,000 cells/well in
medium supplemented with 10 μM sulforaphane (SFPH,
Sigma) (negative control), or 1.8 μg/mL or 3.6 μg/mL
IPSE. The ibidi plate was incubated for 5 h in a humidified
atmosphere of 5% CO2 in air at 37 °C in a microscope
stage top incubator (OKOLAB, Pozzuoli, Naples, Italy). At
intervals, photomicrographs of cells and nascent and de-
veloped tubules were collected using a Leica DMi8 auto-
mated platform microscope under bright field at 2.5 ×
magnification, and LASX software (Leica).
Analysis of tubule formation
Automated angiogenesis assessment was performed on
TFA 4902 pixel images by ImageJ (NIH) with the phase-
contrast Angiogenesis Analyzer plugin tool as described
[19, 20]. Settings used were as follows: 10 pixel mini-
mum object size; 25 pixel minimum branch size; 2500
pixel artefactual loop size; 25 pixel isolated element size
threshold; 30 pixel master segment size threshold; with
iteration number of 3. The four output metrics (mesh
count, segment count, segment length, and junction
count) were either plotted directly or as a percentage
relative to the medium-alone blank treatment (treatment
measure divided by medium-alone measure). A two-way
ANOVA with Holm–Sidak’s multiple comparisons test
was used to compare IPSE treatment against medium-
alone blank control for the four metrics with P ≤ 0.05
deemed significant.
Combining the four metrics into a single evenly
weighted variable was accomplished through the calcula-
tion of Z standardized scores that were based on popula-
tion values [21]. The formula below generates the Z score
and represented the distance between the raw score and
the population mean in units of the SD. Population values
were estimated from 39 treatment replicates.
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The combined robust Z score (Z*) was generated for
each replicate from the median Z score of the four met-
rics. Z* scores were plotted, and IPSE treatments com-
pared to medium-alone blank control using one-way
ANOVA with Holm–Sidak’s multiple comparisons test,
P ≤ 0.05 was considered to be statistically significant.
Cell cycle analyses and CFSE assay
The human bladder epithelium (urothelium) cell line
HCV-29 was grown in T-75 tissue culture flasks in
complete DMEM media (Gibco) under 5% CO2 at 37 °C.
For cell cycle assays, 1 × 105 urothelial cells were co-
incubated with IPSE. Following 48 h of culture, the cells
were fixed and stained with propidium iodide for cell
cycle analysis. For CFSE assays to assess cell prolifera-
tion, cells were stained with the CFSE dye prior to
stimulation with IPSE and cultured for 48 h. The CFSE
dye was evaluated post-culture by flow cytometry using
the FITC channel. The intensity of CFSE dye, which
halves with each cell cycle, was used to track the genera-
tions of urothelial cells.
Endocytosis assays
HCV-29 human derived urothelial cells [see [22]] were
grown in MEM (Thermo Fisher Scientific, Waltham,
MA) with 10% fetal bovine serum (Sigma-Aldrich, St.
Louis, MO). For internalization assays, floating cells and
adherent cells (released via 0.12% trypsin (Sigma-Al-
drich, St. Louis, MO) without EDTA) were washed in
fresh medium, and aliquoted into 24 well plates at 200,
000 cells/mL in 1 mL. The cells were incubated with
Alexa 488-labeled H03 at 1 μg/mL (H03 was conjugated
to Alexa 488 using a kit from Thermofisher Scientific,
Waltham, MA) for 16 h at 37 °C. Cells were released via
0.12% trypsin without EDTA and washed 3 times with
PBS (Sigma-Aldrich, St. Louis, MO). 0.4% trypan blue
(Thermofisher Scientific, Waltham, MA) was added to
the cells (1:4) to quench extracellular Alexa 488 signal.
The cells were analyzed by flow cytometry (Beckman
Coulter, CytoFLEX) to isolate the intracellular Alexa 488
signal. Data were analyzed using FlowJo and GraphPad.
Statistical analysis
Statistical analyses were performed using GraphPad
software. Except where noted otherwise, the Mann-
Whitney U test and Student’s t test were used to evalu-
ate statistical significance for nonparametrically and
parametrically distributed data, respectively. P values of
< 0.05 were defined as significant.
Results
S. haematobium eggs trigger urothelial hyperplasia of the
bladder
We sought to determine whether S. haematobium eggs
alone, in the absence of S. haematobium adult worms,
were sufficient to induce urothelial hyperplasia in the
bladder seen during urogenital schistosomiasis. To ad-
dress the question, we injected S. haematobium eggs
into the mouse bladder wall. Five weeks following egg
injection, the urothelial lining of the bladder still exhib-
ited significant hyperplasia (up to 12-cell thick urothe-
lium compared to three cells characteristic of quiescent
mouse bladder, Fig. 1). Thus, S. haematobium eggs were
sufficient to trigger bladder urothelial hyperplasia.
S. haematobium eggs initiate proliferation of bladder
blood vessels with increased permeability
Hematuria is a hallmark sign of urogenital schistosomia-
sis (UGS). By definition, hematuria involves leakage of
erythrocytes from the lumen of blood vessels into sur-
rounding bladder tissues and the bladder lumen. UGS is
also associated with angiogenic changes in the bladder.
We tested whether S. haematobium eggs were sufficient,
without the presence of S. haematobium worms, to
Z ¼ treatment metric value −metric population meanð Þ=population standard deviationZ
¼ treatment metric value −metric population meanð Þ=population standard deviation
Fig. 1 Schistosoma haematobium eggs are sufficient to induce
urothelial hyperplasia in the bladder. Mice underwent bladder wall
injection with S. haematobium eggs. Five weeks later, their bladders
were harvested, processed, sectioned, and stained with hematoxylin
and eosin. Image shows the typical hyperplastic urothelium (more
than 3 cell layers thick) resulting from egg injection
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initiate angiogenesis and increase vascular permeability.
Bladder wall injection of mice with S. haematobium eggs
induced angiogenesis (Fig. 2a) featuring dilated, leaky
blood vessels (Fig. 2b). We conclude that S. haemato-
bium eggs suffice to orchestrate bladder angiogenesis
and vascular leakiness.
IPSE is internalized by endothelial and urothelial cells
We next assayed the capacity of HCV-29 urothelial and
EOMA endothelial cells to take up H03-H-IPSE. Using
Alexa 488-labeled H03-H-IPSE, we noted that both cell
types readily uptake the protein (Fig. 3).
IPSE induces tubule formation by endothelial cells
Having demonstrated that whole S. haematobium eggs
induce angiogenesis in vivo, we next sought to deter-
mine if recombinant H03-H-IPSE protein alone could
induce similar changes in endothelial cells in vitro. In
vitro tubule formation by the mouse 3B-11 endothelial
cell line was enhanced by addition of 1.8 μg/mL or
3.6 μg/mL H03-H-IPSE to cultures (Additional file 1
and 2), indicating that this protein is pro-angiogenic
(p < 0.05).
IPSE mediates urothelial cell proliferation in a nuclear
localization sequence-dependent manner
Given S. haematobium eggs stimulate urothelial hyper-
plasia in the bladder, we next assayed the ability of
recombinant H03-H-IPSE protein to trigger the in vitro
equivalent, proliferation of urothelial cells. Electrical
impedance measurements of cellular proliferation using
the xCELLigence platform revealed that incubation of
HCV-29 human urothelial cells with 43 pmol, but not
216 or 864 pmol (possibly cytotoxicity), of H03-H-IPSE
induced proliferation of the urothelial cells (Fig. 4a).
The pro-proliferative effect of H03-H-IPSE on urothe-
lial cells was also verified using CFSE staining. These
assays demonstrated that H03-H-IPSE, up to the tested
concentration of 65 pmol, drove proliferation of HCV-29
cells in a concentration-dependent fashion (Fig. 4b).
H06-H-IPSE also induced proliferation of HCV-29 cells.
Incubation of HCV-29 cells with a nuclear localization
sequence mutant of H03-H-IPSE failed to enhance pro-
liferation, suggesting that H03-H-IPSE’s pro-proliferative
influence depends upon the protein’s ability to migrate
into the nucleus of the host cell.
IPSE skews urothelial cell cycle status in a nuclear
localization sequence-dependent fashion
Our findings that H03-H-IPSE stimulated urothelial pro-
liferation led us to examine whether this protein alters
the cell cycle status of urothelial cells. Through propi-
dium iodide staining of H03-H-IPSE-exposed HCV-29
urothelial cells, we ascertained that this protein indeed
skews cells towards S-phase (Fig. 5). The ability of H03-
H-IPSE to bias urothelial cells towards S-phase was
nuclear localization sequence-dependent, since the nu-
clear localization sequence mutant form of H03-H-IPSE
did not change the cell cycle status of HCV-29 cells.
Fig. 2 Schistosoma haematobium eggs are sufficient to induce angiogenesis and increased vascularpermeability in the bladder. a, Mice
underwent bladder wall injection with S. haematobium eggs. Four days later their bladders were harvested, processed, sectioned, and stained
with hematoxylin and eosin. Left and right panels show bladders injected with controlvehicle or S. haematobium eggs, respectively. Arrowheads
indicate erythrocyte-containingblood vessels, which are more numerous in egg- versus vehicle-injected bladders. b, Miceunderwent bladder wall
injection with S. haematobium eggs. Three weeks later mice were administered FITC-lectin to label blood vessels and Red Fluoro-Max microbeads
(to measure vascular permeability) and their bladders harvested and examined by confocal microscopy. Left, middle, and right columns show
FITC channel, red channel, and merged channels, respectively. Detection of red signal indicates leakage of Red Fluoro-Max microbeads out of
blood vessels. Each row consists of representative images from a single mouse (n = 3 controls, n = 3 egg-injected)
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Discussion
Schistosomiasis affects more than 200 million people
worldwide [23]. The majority of cases affect the urogeni-
tal tract, caused mostly by S. haematobium. As a blood
fluke, S. haematobium adult worms live primarily in the
pelvic veins, where worm pairs lay eggs that lodge in the
pelvic organs. Eggs laid in the bladder induce granuloma
formation, which is thought to facilitate passage of eggs
into the urinary stream [24, 25]. Eggs voided into fresh
bodies of water hatch into miracidia, which infect inter-
mediate snail hosts. Infected snails release cercariae, the
larval stage which infects humans.
The complex life cycle of S. haematobium depends upon
the parasite successfully negotiating host tissue and im-
mune responses that may threaten its survival. For instance,
hematuria is a cardinal sign of urogenital schistosomiasis,
and represents a compromised urothelial and endothelial
barrier which allows S. haematobium to continue reprodu-
cing. However, unchecked damage to the urothelium and
bladder blood vessels results in hemorrhage and even host
death, which is counterproductive to any parasite [26].
Hence, it is possible that S. haematobium and humans have
co-evolved survival strategies. The exuberant proliferative
response of the urothelium and endothelium to S. haema-
tobium eggs may be one such strategy, since this likely pro-
motes bladder tissue repair.
Schistosomes may induce host tissue repair responses,
in particular angiogenesis, to promote egg expulsion.
Turner et al. reported that deposition of S. mansoni eggs
in Peyers’ patches of the mouse small intestine is associ-
ated with vascular remodeling and an expanded venule
network [27]. In mice deficient in Peyers’ patches, egg
excretion is lessened, leading to more eggs entrapped in
tissues, and consequently worsened host morbidity. We
postulate that S. haematobium eggs similarly initiate
angiogenesis in the bladder to facilitate their expulsion
into the urinary stream.
Angiogenesis and urothelial proliferation benefit the S.
haematobium-infected host in the short term but have
been postulated to facilitate bladder carcinogenesis. S.
haematobium is one of a handful of helminths that are
known to be carcinogenic [28]. Angiogenesis, such as
that seen in bladders containing S. haematobium eggs, is
a crucially important process for tumors, since their
rapid growth puts them at risk of outstripping their
blood supply. Expansion of local vascular beds may also
enhance hematogenous spread of metastases. Urogenital
schistosomiasis is associated with urothelial hyperplasia,
a potentially pre-cancerous feature in the bladder.
Despite the prominence of urothelial and endothelial
aberrations in urogenital schistosomiasis, our comprehen-
sion of the underpinnings of these pathological processes
is limited. One mystery is whether S. haematobium eggs,
without adult worms, are sufficient to activate urothelial
hyperplasia and angiogenesis in the bladder. This is a sig-
nificant matter because S. haematobium worms can live
for years within their human hosts, whereas parasite eggs
can remain in the bladder wall for decades and continue
to drive chronic inflammation, even after successful treat-
ment of infection. Understanding the contributions of S.
haematobium worms to bladder pathogenesis is important
to improving our knowledge base of chronic urogenital
schistosomiasis. To that end, we observed that when S.
haematobium eggs are injected into the bladder walls of
mice, this elicits significant urothelial hyperplasia, angio-
genesis, and vascular leakiness. These bladder changes are
not seen when mice are injected with control vehicle.
These findings intimate that S. haematobium worms play
no or minimal role in the pathological changes of the
bladder associated with urogenital schistosomiasis. Finally,
these findings point to one or more S. haematobium egg-
associated factors which mediate urothelial and endothe-
lial changes.
We hypothesized that one of these egg-associated fac-
tors was the Interleukin-4 inducing Principle of Schisto-
soma mansoni Eggs (IPSE) [29]. IPSE, also known as α-1
[8], features many host immunomodulatory functions.
First, IPSE ligates Fcε receptor-bound IgE on the surface
of mast cells and basophils to trigger IL-4 and IL-13 secre-
tion [29–32]. Splenocytes from mice immunized with
IPSE produce IFN-gamma, TNF, IL-4, IL-5, and IL-13
[33]. IPSE also binds to immunoglobulins on the surface
of B regulatory cells (Bregs) and thereby induces IL-10
production by these cells [34]. IPSE can also sequester
chemokines; it was previously known as S. mansoni
chemokine-binding protein (smCKBP) [35]. Lastly, IPSE
contains a nuclear localization sequence which directs the
Fig. 3 H03-H-IPSE is internalized by endothelial and urothelial cells.
Alexa 488-labeled H03-H-IPSE was incubated with HCV-29 urothelial
and EOMA endothelial cells. Extracellular signal was quenched with
trypan blue, and the remaining intracellular Alexa 488 signal
measured by flow cytometry. Each symbol denotes an individual
culture well replicate. Figure shows one of two
representative experiments
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Fig. 4 H-IPSE enhances urothelial cell proliferation in a nuclear localization sequence-dependent fashion. a, H03-H-IPSE increases urothelial cell
proliferation. HCV-29 human urothelial cells were incubated with 0, 43, 216, or 864 pmol of H03-H-IPSE and electrical impedance (cellular
proliferation) measured in real-time using the xCELLigence platform. b, left panel, CFSE-labeled HCV-29 human urothelial cells were incubated
with up to 65 pmol of H03-H-IPSE and analyzed for evidence of proliferation (decreased CFSE content per cell with each successive generation of
cells). Each symbol denotes an individual culture well replicate (n = 8 for each culture condition). B, middle panel, CFSE-labeled HCV-29 human
urothelial cells were incubated with up to 65 pmol of H06-H-IPSE and analyzed for evidence of proliferation. Each symbol denotes an individual
culture well replicate (n = 8 for each culture condition). B, right panel, CFSE-labeled HCV-29 human urothelial cells were incubated with up to 65
pmol of a nuclear localization mutant of H03-H-IPSE and analyzed for evidence of proliferation (decreased CFSE content per cell with each
successive generation of cells). Each symbol denotes an individual culture well replicate
Fig. 5 H-IPSE polarizes urothelial cell cycle status in a nuclear localization sequence-dependent manner. Left panel, propidium iodide-labeled
HCV-29 human urothelial cells were incubated with up to 65 pmol of H03-H-IPSE and analyzed for cell cycle status. Each symbol denotes an
individual culture well replicate (n = 8 for each culture condition). Middle panel, propidium iodide-labeled HCV-29 human urothelial cells were
incubated with up to 65 pmol of H06-H-IPSE and analyzed for cell cycle status. Each symbol denotes an individual culture well replicate (n = 8 for
each culture condition). Right panel, CFSE-labeled HCV-29 human urothelial cells were incubated with up to 65 pmol of a nuclear localization
mutant of H03-H-IPSE and analyzed for cell cycle status. Each symbol denotes an individual culture well replicate
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protein to host cell nuclei [9, 11], where it modulates tran-
scription [10, 36].
The manifold immunomodulatory properties of IPSE
may be particularly relevant given the co-endemicity of
urogenital schistosomiasis with other infections that trig-
ger significant cytokine responses, such as malaria and
HIV. COVID-19-associated cytokine dysregulation may
also be altered by IPSE released by S. haematobium eggs
in co-infected individuals. These are important areas for
future inquiry.
Although IPSE has multiple immunomodulatory prop-
erties, our in vitro work indicates that H03-H-IPSE
mediates its urothelial and endothelial effects via non-
immune mechanisms, including through its nuclear
localization sequence. The similar uptake of H03-H-IPSE
by endothelial and urothelial cells hints that endocytosis
occurs in either a non-specific fashion, or that these cell
types share a receptor for H03-H-IPSE. We speculate that
once IPSE is internalized by host cells, it may trigger pro-
carcinogenic programs. Indeed, Roderfeld et al. showed
that IPSE activated hepatocellular carcinoma-associated
proto-oncogenes, namely c-Jun and its associated signal-
ing molecule, STAT3 [36]. This supports a potential role
for H03-H-IPSE in promoting bladder oncogenesis.
Another interesting issue regarding the potential
causal link between IPSE and schistosomal bladder car-
cinogenesis is whether this molecule promotes the high
rates of squamous cell carcinoma seen in association
with S. haematobium infection [37–40]. This remains an
open question, since we did not have an immortalized
schistosomiasis-associated squamous cell bladder carcin-
oma cell line available for testing. However, schistosomal
bladder cancer can still be associated with carcinomas
arising from the urothelium, the tissue of origin for the
HCV-29 cells tested herein.
Superficially, targeting IPSE to prevent schistosomal blad-
der cancer appears to be a worthy prophylactic approach.
However, it has been reported that immunization of S.
mansoni mice with IPSE leads to larger granulomas with
enhanced macrophage activity and a mixed type 1 and type
2 immune response [33]. Since granulomas contribute to
host tissue fibrosis, neutralization of IPSE during schisto-
somiasis may actually be undesirable. Thus, a vaccine
directed against IPSE may not ameliorate the pathology of
schistosomiasis.
We speculate that given IPSE is an abundant egg-
secreted protein, diagnostic assays designed to measure
IPSE expression in S. haematobium-infected individuals
may provide valuable morbidity assessment and prognostic
information that is not available through current methods.
This investigation has noteworthy limitations. Al-
though we hypothesize that H03-H-IPSE is sufficient to
drive urothelial and endothelial proliferation and related
effects, we have not demonstrated that it is necessary.
There may be additional S. haematobium egg-derived
factors which contribute to urothelial hyperplasia and
angiogenesis during urogenital schistosomiasis. Ideally,
transgenic approaches would be used to show that H03-
H-IPSE is critical in angiogenesis and urothelial hyper-
plasia in vivo. This approach could be in reach for future
studies given that both germline transgenesis and
genome editing of egg-expressed genes have now been
reported in other work [41, 42]. Another important
caveat of our work is that the in vivo studies were per-
formed using female mice. Men are at higher risk than
women for development of all forms of bladder cancer
(i.e., both schistosomiasis-related and -unrelated). Part of
this risk is due to the importance of androgen receptor
signaling in bladder carcinogenesis [43]. There are also
reports of a possible relationship between estrogen-DNA
adducts and schistosomal bladder oncogenesis [44]. In
Honeycutt et al., we did not observe obvious differences
in H&E-based histology of granulomatous inflammation
in wild type male versus female mice [2]. We also did
not observe histological differences when these wild type
mice were administered tamoxifen versus control
vehicle, suggesting that estrogen receptor-mediated
signaling did not cause apparent differences. However, it
is possible that sex and sex hormones influence other as-
pects of urogenital schistosomiasis that we have not yet
studied.
In conclusion, we have provided data that support the
hypothesis that S. haematobium eggs are sufficient to
initiate bladder urothelial hyperplasia, angiogenesis, and
vascular permeability associated with urogenital schisto-
somiasis. These changes may be orchestrated by IPSE.
Our observations are particularly striking considering
that IPSE can increase proliferation of transformed
urothelial and endothelial cell lines that, at baseline,
already exhibit significant proliferation. IPSE may indeed
be a pro-oncogenic factor of S. haematobium.
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